Huang Shi Bin - Net Worth and Insider Trading

Huang Shi Bin Net Worth

The estimated net worth of Huang Shi Bin is at least $121 Million dollars as of 2025-07-19. Huang Shi Bin is the Supervisors of Guangdong Zhongsheng Pharmaceutical Co Ltd and owns about 6,860,000 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) stock worth over $121 Million. Details can be seen in Huang Shi Bin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Huang Shi Bin has not made any transactions after 2013-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Huang Shi Bin

Huang Shi Bin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Huang Shi Bin owns 1 companies in total, including Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) .

Click here to see the complete history of Huang Shi Bin’s form 4 insider trades.

Insider Ownership Summary of Huang Shi Bin

Ticker	Company	Transaction Date	Type of Owner
SZSE:002317	Guangdong Zhongsheng Pharmaceutical Co Ltd	2013-05-27	Supervisors

Huang Shi Bin Latest Holdings Summary

Huang Shi Bin currently owns a total of 1 stock. Huang Shi Bin owns 6,860,000 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) as of May 27, 2013, with a value of $121 Million.

Latest Holdings of Huang Shi Bin

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:002317	Guangdong Zhongsheng Pharmaceutical Co Ltd	2013-05-27	6,860,000	17.63	120,941,800

Holding Weightings of Huang Shi Bin

Huang Shi Bin Form 4 Trading Tracker

According to the SEC Form 4 filings, Huang Shi Bin has made a total of 0 transactions in Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) over the past 5 years. The most-recent trade in Guangdong Zhongsheng Pharmaceutical Co Ltd is the sale of 1,000,000 shares on May 27, 2013, which brought Huang Shi Bin around $20 Million.

Insider Trading History of Huang Shi Bin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Huang Shi Bin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Huang Shi Bin Ownership Network

Ownership Network List of Huang Shi Bin

No Data

Ownership Network Relation of Huang Shi Bin

Huang Shi Bin Owned Company Details

What does Guangdong Zhongsheng Pharmaceutical Co Ltd do?

Who are the key executives at Guangdong Zhongsheng Pharmaceutical Co Ltd?

Huang Shi Bin is the Supervisors of Guangdong Zhongsheng Pharmaceutical Co Ltd. Other key executives at Guangdong Zhongsheng Pharmaceutical Co Ltd include Directors & executives Chen Yong Hong , Executives Zhao Xi Ping , and Secretary & Director Zhang Yu Chong .

Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) Insider Trades Summary

Over the past 18 months, Huang Shi Bin made no insider transaction in Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317). Other recent insider transactions involving Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) include a net purchase of 202,400 shares made by Chen Yong Hong ,

In summary, during the past 3 months, insiders sold 0 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317) were sold and 202,400 shares were bought by its insiders, resulting in a net purchase of 202,400 shares.

Guangdong Zhongsheng Pharmaceutical Co Ltd (SZSE:002317)'s detailed insider trading history can be found in Insider Trading Tracker table.

Guangdong Zhongsheng Pharmaceutical Co Ltd Insider Transactions

No Available Data

Huang Shi Bin Mailing Address

Above is the net worth, insider trading, and ownership report for Huang Shi Bin. Currently GuruFocus does not have mailing address information for Huang Shi Bin.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.